Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT

Journal of Nuclear Medicine

Volumn 48, Issue 10, 2007, Pages 1662-1669

  Inglese, Eugenio ^a   Leva, Lucia ^a   Matheoud, Roberta ^b   Sacchetti, Gianmauro ^a   Secco, Chiara ^b   Gandolfo, Patrizia ^c   Brambilla, Marco ^b,d   Sambuceti, Gianmario ^c  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b MAGGIORE DELLA CARITÀ HOSPITAL   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d Medical Physics Department   (Italy)

Author keywords

18F FDG; Cardiac uptake; Whole body PET CT

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; HEART DISEASE; HEART MUSCLE; HUMAN; MALE; NEOPLASM; PRIORITY JOURNAL; WHOLE BODY CT; WHOLE BODY PET;

FASTING; FEMALE; FLUORODEOXYGLUCOSE F18; HEART; HEART DISEASES; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; MYOCARDIUM; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TISSUE DISTRIBUTION; TOMOGRAPHY, X-RAY COMPUTED; WHOLE BODY IMAGING;

EID: 35348902808     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.107.041574     Document Type: Article

References (16)

1. Tillisch J, Brunken R, Marshall R, et al. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med. 1986;314:884-888.
2. Sambuceti G, Giorgetti A, Corsiglia L, et al. Perfusion-contraction mismatch during inotropic stimulation in hibernating myocardium. J Nucl Med. 1998;39:396-402.
3. 18F-fluoro-deoxyglucose positron emission tomography for the detection of myocardial viability. Eur Heart J. 2001;22:1691-1701.
4. Knuuti J, Schelbert HR, Bax JJ. The need for standardisation of cardiac FDG PET imaging in the evaluation of myocardial viability in patients with chronic ischaemic left ventricular dysfunction. Eur J Nucl Med Mol Imaging. 2002;29:1257-1266.
5. Bonow RO, Dilsizian V, Cuocolo A, Bacharach SL. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction: comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose. Circulation. 1991;83:26-37.
6. Marzullo P, Parodi O, Sambuceti G, et al. Residual coronary reserve identifies segmental viability in patients with wall motion abnormalities. J Am Coll Cardiol. 1995;26:342-350.
7. Gropler RJ, Siegel BA, Lee KJ, et al. Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans. J Nucl Med. 1990;31:1749-1756.
8. Fukuchi K, Otha H, Matsamura K, Ishida Y. Benign variation and incidental abnormalities of myocardial FDG uptake in the fasting state as encountered during routine oncology positron emission tomography studies. Br J Radiol. 2007;80:3-11.
9. 18F-FDG PET. Nucl Med Commun. 2005;26:787-791.
10. de Groot M, Meeuwis APW, Kok PJM, Corstens FHM, Oyen WJG. Influence of blood glucose level, age and fasting period on non-pathological FDG uptake in heart and gut. Eur J Nucl Med Mol Imaging. 2005;32:98-101.
11. Germano G, Kavanagh PB, Waechter P, et al. A new algorithm for the quantitation of myocardial perfusion SPECT. I. Technical principles and reproducibility. J Nucl Med. 2000;41:712-719.
12. Hays WL. Statistics. 4th ed. Fort Worth, TX: Holt, Rinehart and Winston Inc; 1988.
13. Streiner DL, Norman GR. Health Measurement Scales. New York, NY: Oxford University Press; 1989.
14. Tamaki N, Yonekura Y, Kawamoto M, et al. Simple quantification of regional myocardial uptake of fluorine-18-deoxyglucose in the fasting condition. J Nucl Med. 1991;32:2152-2157.
15. Choi Y, Brunken RC, Hawkins A, et al. Factors affecting myocardial 2-[F-18]fluoro-2-deoxy-D-glucose uptake in positron emission tomography studies of normal humans. Eur J Nucl Med. 1993;20:308-318.
16. Panjrath GS, Jain D. Monitoring chemotherapy-induced cardiotoxicity: role of cardiac nuclear imaging. J Nucl Cardiol. 2006;13:415-426.